РусскийEnglish (UK)
     
 

Chistiakov DA1, Orekhov AN2, Bobryshev YV3.
J Mol Cell Cardiol. 2016 May 12;97:47-55. doi: 10.1016/j.yjmcc.2016.05.007. [Epub ahead of print]

Abstract

Expression of microRNA (miR)-126 is enriched in endothelial cells (ECs) and endothelial progenitor cells (EPCs). MiR-126 is considered a master regulator of physiological angiogenesis. In embryonic vasculogenesis, this miRNA is involved in induction of angiogenic signaling, supports differentiation of embryonic stem cells to EPCs and ECs, and promotes EC maturation. However, in mature ECs and adult EPCs, miR-126 contributes to vascular homeostasis by inhibiting angiogenesis and maintaining the quiescent endothelial phenotype associated with increased vascular integrity and inhibited proliferation and motility. In a case of vessel injury and/or hypoxia, miR-126 up-regulation activates EPCs and ECs and contributes to vascular healing and neovessel formation. Indeed, miR-126 exhibits vasculoprotective and atheroprotective properties. The promising regenerative and proangiogenic potential of this miRNA will be helpful for development of cardioprotective strategies and cardiovascular repair therapies of myocardial infarction, heart failure, and other cardiovascular pathology.

Copyright © 2016 Elsevier Ltd. All rights reserved.

KEYWORDS:

Angiogenesis; Atherosclerosis; Endothelial cell; Endothelial progenitor cell; Endothelial quiescence; Vascular repair; miR-126